The DOI matches its Crossref record; 48 of the 54 references it cites were found in a registry or an index.
Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009–2017
Abstract
OBJECTIVES: To study the national prevalence of 10 developmental disabilities in US children aged 3 to 17 years and explore changes over time by associated demographic and socioeconomic characteristics, using the National Health Interview Survey. METHODS: Data come from the 2009 to 2017 National Health Interview Survey, a nationally representative survey of the civilian noninstitutionalized population. Parents reported physician or other health care professional diagnoses of attention-deficit/hyperactivity disorder; autism spectrum disorder; blindness; cerebral palsy; moderate to profound hearing loss; learning disability; intellectual disability; seizures; stuttering or stammering; and other developmental delays. Weighted percentages for each of the selected developmental disabilities and any developmental disability were calculated and stratified by demographic and socioeconomic characteristics. RESULTS: From 2009 to 2011 and 2015 to 2017, there were overall significant increases in the prevalence of any developmental disability (16.2%–17.8%, P < .001), attention-deficit/hyperactivity disorder (8.5%–9.5%, P < .01), autism spectrum disorder (1.1%–2.5%, P < .001), and intellectual disability (0.9%–1.2%, P < .05), but a significant decrease for any other developmental delay (4.7%–4.1%, P < .05). The prevalence of any developmental disability increased among boys, older children, non-Hispanic white and Hispanic children, children with private insurance only, children with birth weight ≥2500 g, and children living in urban areas and with less-educated mothers. CONCLUSIONS: The prevalence of developmental disability among US children aged 3 to 17 years increased between 2009 and 2017. Changes by demographic and socioeconomic subgroups may be related to improvements in awareness and access to health care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Developmental delays and disabilities are common in children, affecting up to 18% of children aged 3 to 17 years in the United States, according to recent national estimates.1”
From Early Childhood Care Coordination Through 211: A Randomized Clinical Trial (2024) · cites this paper as [1]
In the citing paper
“In a large US parent report survey in 88,530 children aged 3–17 years, the rate of any neurodevelopmental condition, including ADHD, autism, speech fluency disorder (stuttering), learning disorders, intellectual disabilities or any other developmental delay was 12.6% in females and 22.7% in males12.”
From Sex and gender in neurodevelopmental conditions (2023) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Self-citationGlobal Prevalence of Autism and Other Pervasive Developmental Disorders
Elsabbagh, M., Divan, G., Koh, Y., Kim, Y. S., Kauchali, S., Marcín, C., Montiel‐Nava, C., Patel, V., Paula, C. S., Wang, C., et al. (2012) · Autism Research · doi:10.1002/aur.239 · Cited by 2,636 · cited 1×
“The reported prevalence of ASD in the United States and other industrialized countries has shown marked increases in recent decades.(2,20) However, understanding changes to ASD prevalence remains particularly challenging given that the diagnosis of ASD is based on a symptom profile, and health care provider and school…”
BackgroundTaylor, C. A., Bell, J. M., Breiding, M. J., & Xu, L. (2017) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6609a1 · Cited by 2,331
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Identification and Evaluation of Children With Autism Spectrum Disorders
Johnson, C. P., Myers, S. M., & and the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2361 · Cited by 2,011
Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt261 · Cited by 1,822 · cited 1×
“The increase in prevalence of diagnosed ADHD among US children and adolescents since the late 1990s has been well documented, although there is evidence that the prevalence of ADHD symptoms and impairment has remained steady over time.(15,16) Taken together, this suggests that the increases in diagnosed prevalence cou…”
ResultTrends in the prevalence of developmental disabilities in US children, 1997-2008
Boyle, C. A., Boulet, S., Schieve, L. A., Cohen, R. A., Blumberg, S. J., Yeargin-Allsopp, M., Visser, S., & Kogan, M. D. (2011) · Pediatrics · doi:10.1542/peds.2010-2989 · Cited by 1,732 · cited 2×
“…be formally recognized until a child is in school.23 Overall, the general consistency of demographic patterns with previous studies, particularly Boyle et al,11 suggests that underlying, contributing factors, such as service availability, continue to be associated with the prevalence of…”
MethodResultSelf-citation
Research works printed but not linked: 2
- Health Resources and Services Administration, 2016, Designated Health Professional Shortage Areas (HPSA) Statistics
- Majnemer, 1998, Semin Pediatr Neurol, 62
Cited by
Sorted by citations
Maenner, M. J., Shaw, K. A., Baio, J., EdS1, Washington, A., Patrick, M., DiRienzo, M., Christensen, D. L., Wiggins, L. D., Pettygrove, S., et al. (2020) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6904a1 · Cited by 3,780
“The 2016 NSCH and the 2015–2017 NHIS both estimated ASD prevalence at 25 per 1,000 children aged 3–17 years (13,29).”
BackgroundSelf-citationMental Health Surveillance Among Children — United States, 2013–2019
Bitsko, R. H., Claussen, A. H., Lichstein, J., Black, L. I., Jones, S. E., Danielson, M. L., Hoenig, J. M., Davis Jack, S. P., Brody, D. J., Gyawali, S., et al. (2022) · MMWR Supplements · doi:10.15585/mmwr.su7102a1 · Cited by 1,723
“Consistent with previous studies, boys had a higher prevalence than girls of ADHD, behavioral or conduct problems, ASD, Tourette syndrome, and rates of suicide (1,34,38,42,82,86), and girls had higher estimated prevalences of depression, suicidal ideation, and attempted suicide (1,34).”
BackgroundSelf-citationHampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., et al. (2023) · Pediatrics · doi:10.1542/peds.2022-060640 · Cited by 1,389
Maternal immune activation and neuroinflammation in human neurodevelopmental disorders
Han, V. X., Patel, S., Jones, H. F., & Dale, R. C. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00530-8 · Cited by 683
Five-Year Trends in US Children’s Health and Well-being, 2016-2020
Lebrun‐Harris, L. A., Ghandour, R. M., Kogan, M. D., & Warren, M. D. (2022) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2022.0056 · Cited by 378
Self-citationDanielson, M. L., Claussen, A. H., Bitsko, R. H., Katz, S. M., Newsome, K., Blumberg, S. J., Kogan, M. D., & Ghandour, R. (2024) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2024.2335625 · Cited by 347
“Otherwise, patterns of prevalence across sociodemographic groups were generally consistent with previous data (Bitsko et al., 2022; Danielson, Bitsko, et al., 2018; Pastor et al., 2015; Perou et al., 2013; Zablotsky & Black, 2020; Zablotsky et al., 2019).”
BackgroundResultSelf-citationFetal alcohol spectrum disorders
Popova, S., Charness, M. E., Burd, L., Crawford, A., Hoyme, H. E., Mukherjee, R., Riley, E. P., & Elliott, E. J. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00420-x · Cited by 350
Sex and gender in neurodevelopmental conditions
Bölte, S., Neufeld, J., Marschik, P. B., Williams, Z. J., Gallagher, L., & Lai, M.-C. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00774-6 · Cited by 249
Paracetamol use during pregnancy — a call for precautionary action
Bauer, A. Z., Swan, S. H., Kriebel, D., Liew, Z., Taylor, H. S., Bornehag, C.-G., Andrade, A. M., Olsen, J., Jensen, R. H., Mitchell, R. T., et al. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00553-7 · Cited by 228
Hadders‐Algra, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040861 · Cited by 243
“In high income countries the prevalence of CP is 1–3‰ [1–3], that of intellectual disability is about 1% [2,4] and that reported for ASD is 0.”
BackgroundGenetic Testing in Neurodevelopmental Disorders
Savatt, J. M., & Myers, S. M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.526779 · Cited by 237
“With a combined prevalence of ∼17% among 3- to 17-year-old children in the United States, neurodevelopmental disabilities are the most prevalent chronic medical conditions encountered in pediatric primary care (1).”
BackgroundOverdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Kazda, L., Bell, K., Thomas, R., McGeechan, K., Sims, R., & Barratt, A. L. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.5335 · Cited by 255
Including Children with Developmental Disabilities in the Equation During this COVID-19 Pandemic
Aishworiya, R., & Kang, Y. Q. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-020-04670-6 · Cited by 207
Clinical Practice Guideline: Tympanostomy Tubes in Children (Update)
Rosenfeld, R. M., Tunkel, D. E., Schwartz, S., Anne, S., Bishop, C. E., Chelius, D. C., Hackell, J. M., Hunter, L. L., Keppel, K. L., Kim, A. H., et al. (2022) · Otolaryngology · doi:10.1177/01945998211065662 · Cited by 174
“About 18% of children aged 3 to 17 years in the United States have a developmental disability, with increasing prevalence over the past decade.(164) These include children with primary language impairments and others with autism spectrum disorders or conditions that adversely affect cognitive and linguistic developmen…”
BackgroundPosserud, M., Skretting Solberg, B., Engeland, A., Haavik, J., & Klungsøyr, K. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13368 · Cited by 135
Leblond, C. S., Le, T.-L., Malesys, S., Cliquet, F., Tabet, A., Delorme, R., Rolland, T., & Bourgeron, T. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103623 · Cited by 144
Genes, Gender Inequality, and Educational Attainment
Herd, P., Jeremy Freese, A., Sicinski, K., Domingue, B. W., Harris, K. M., Wei, C., & Hauser, R. M. (2019) · American Sociological Review · doi:10.1177/0003122419886550 · Cited by 123
From neurodiversity to neurodivergence: the role of epistemic and cognitive marginalization
Legault, M., Bourdon, J.-N., & Poirier, P. (2021) · Synthese · doi:10.1007/s11229-021-03356-5 · Cited by 150
Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States
Straub, L., Bateman, B. T., Hernández–Dı́az, S., York, C., Lester, B. M., Wisner, K. L., McDougle, C. J., Pennell, P. B., Gray, K. J., Zhu, Y., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.3815 · Cited by 115
Hall, M. B., Willis, D. E., Rodriguez, E. L., & Schwarz, J. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1135559 · Cited by 117
“5% in the last decade (Zablotsky et al., 2019), likely because our understanding of and ability to effectively diagnose various NDDs has improved over time.”
BackgroundBölte, S., Lawson, W. B., Marschik, P. B., & Girdler, S. (2021) · BioEssays · doi:10.1002/bies.202000254 · Cited by 99
“8% of the general population,[5] and heterogeneous in their etiology, neurobiology and presentation.”
BackgroundMichelini, G., Carlisi, C. O., Eaton, N. R., Elison, J. T., Haltigan, J. D., Kotov, R., Krueger, R. F., Latzman, R. D., Li, J. J., Levin-Aspenson, H. F., et al. (2024) · World Psychiatry · doi:10.1002/wps.21225 · Cited by 109
“Difficulties with social communication, attention, learning, motor and cognitive abilities during development affect up to 15% of individuals worldwide, with many more experiencing subthresh-old problems 1,2 .”
Diagnosed Developmental Disabilities in Children Aged 3–17 Years: United States, 2019–2021
Zablotsky, B., Ng, A. E., Black, L. I., & Blumberg, S. J. (2023) · doi:10.15620/cdc:129520 · Cited by 95
“Developmental disabilities are common in children in the United States, and the prevalence has increased in recent years (1).”
BackgroundSelf-citationNeural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders
Gandhi, T., & Lee, C. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592710 · Cited by 97
Ahmad, I., Rashid, J., Faheem, M., Akram, A., Khan, N. A., & Amin, R. U. (2024) · Healthcare Technology Letters · doi:10.1049/htl2.12073 · Cited by 110
“Disorders including autism, ADHD, blindness, and cerebral palsy were listed [8].”
BackgroundRetractedCase, L., Ross, S. M., & Yun, J. (2019) · Disability and health journal · doi:10.1016/j.dhjo.2019.100881 · Cited by 88
Qu, G., Hu, W., Meng, J., Wang, X., Su, W., Liu, H., Ma, S., Sun, C., Huang, C., Lowe, S., et al. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.03.014 · Cited by 90
Cogswell, M., Coil, E., Tian, L. H., Tinker, S., Ryerson, A., Maenner, M., Rice, C., & Peacock, G. (2022) · MMWR. Morbidity and mortality weekly report · doi:10.15585/mmwr.mm7112a3 · Cited by 73
“The prevalences of DDs during 2014–2018, overall and by type, are consistent with 2015–2017 (1).”
BackgroundSelf-citationTranstorno do Espectro do Autismo
Vital, A. A. F., GARCIA, A. H. C., SANTOS, A. P. D., Saad, A. G. D. F., DIAS, C. G. D. F., Miccas, C., de Araújo, C. O., MAGALHÃES, C. M., LOURENÇO, D. P. L., Galeti, F., et al. (2021) · doi:10.29327/558796 · Cited by 86
Morgan, P. L., Woods, A. D., Wang, Y., Farkas, G., Hillemeier, M. M., & Mitchell, C. (2022) · Journal of Learning Disabilities · doi:10.1177/00222194221094019 · Cited by 86
“…identified with disabilities in the ECLS-K: 2011 versus the ECLS-K: 1998, particularly during the earlier grades, is consistent with other work (Zablotsky et al., 2019) reporting increasing developmental disability prevalence possibly resulting from greater disability awareness, screening, and…”
ResultDrug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions
McCracken, J. T., Anagnostou, E. A., Arango, C., Dawson, G., Farchione, T. R., Mantua, V., McPartland, J. C., Murphy, D., Pandina, G., & Veenstra-VanderWeele, J. M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.05.010 · Cited by 89
“5% prevalence in children) (Baio et al., 2018; Christensen et al., 2019; Delobel-Ayoub et al., 2020; Guthrie et al., 2019; Maher et al., 2019; Zablotsky et al., 2019) syndrome of childhood-onset delays and deviations in social communication and interaction, narrowed and unusual interests, repetitive behaviors, and sen…”
BackgroundMicai, M., Fulceri, F., Caruso, A., Guzzetta, A., Gila, L., & Scattoni, M. L. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.027 · Cited by 94
Prevalence of neurodevelopmental disorders among US children and adolescents in 2019 and 2020
Yang, Y., Zhao, S., Zhang, M., Xiang, M., Zhao, J., Chen, S., Wang, H., Han, L., & Ran, J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.997648 · Cited by 76
Li, Y.-A., Chen, Z., Li, X., Gu, M., Xia, N., Chen, G., Zhou, Z.-W., Yasin, G., Xie, H., Wei, X., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.972809 · Cited by 89
Welch, C. J., & Mulligan, K. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052894 · Cited by 76
“93% of children were diagnosed with an NDD [1].”
BackgroundWang, T., Kim, C. N., Bakken, T. E., Gillentine, M. A., Henning, B., Mao, Y., Gilissen, C., Nowakowski, T. J., Eichler, E. E., Acampado, J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203491119 · Cited by 83
Prevalence and Trends in Pediatric-Onset Chronic Conditions in the United States, 1999-2018
Wisk, L. E., & Sharma, N. (2025) · Academic Pediatrics · doi:10.1016/j.acap.2025.102810 · Cited by 71
Wallace, J., Boers, E., Ouellet, J., Afzali, M. H., & Conrod, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-44105-7 · Cited by 70
Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population
Martin, C. L., Wain, K. E., Oetjens, M. T., Tolwinski, K., Palen, E., Hare-Harris, A. E., Habegger, L., Maxwell, E. K., Reid, J. G., Walsh, L. K., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2159 · Cited by 70
Li, Z., Yang, L., Chen, H., Fang, Y., Zhang, T., Yin, X., Man, J., Yang, X., & Lü, M. (2022) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796022000178 · Cited by 73
“(Zablotsky et al., 2019).”
InfluentialBoulton, K., Hodge, M.-A., Jewell, A., Ong, N., Silove, N., & Guastella, A. J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069500 · Cited by 68
Li, Q., Li, Y., Zheng, J., Yan, X., Huang, J., Xu, Y., Zeng, X., Shen, T., Xing, X., Chen, Q., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44472-1 · Cited by 67
Racial disparities in developmental delay diagnosis and services received in early childhood
Gallegos, A., Dudovitz, R., Biely, C., Chung, P. J., Coker, T. R., Barnert, E., Guerrero, A. D., Szilagyi, P. G., & Nelson, B. B. (2021) · Academic Pediatrics · doi:10.1016/j.acap.2021.05.008 · Cited by 66
Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders
Straub, L., Hernández–Dı́az, S., Bateman, B. T., Wisner, K. L., Gray, K. J., Pennell, P. B., Lester, B. M., McDougle, C. J., Suarez, E. A., Zhu, Y., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.0375 · Cited by 71
Sex Differences in Neurodevelopmental Disorders: A Key Role for the Immune System
Breach, M. R., & Lenz, K. M. (2022) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2022_308 · Cited by 62
Diversity and consequences of structural variation in the human genome
Collins, R. L., & Talkowski, M. E. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-024-00808-9 · Cited by 76
Olusanya, B. O., Gladstone, M., Wright, S. M., Hadders-Algra, M., Boo, N.-Y., Nair, M. K. C., Almasri, N., Kancherla, V., Samms-Vaughan, M. E., Kakooza-Mwesige, A., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.894546 · Cited by 64
Hoyle, J., Laditka, J. N., & Laditka, S. B. (2020) · Disability and health journal · doi:10.1016/j.dhjo.2020.101020 · Cited by 64
Mann, M., McMillan, J., Silver, E. J., & Stein, R. E. K. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01295-z · Cited by 70
Rodan, L. H., Stoler, J. M., Chen, E., Geleske, T. A., Vergano, S. A. S., Holm, I. A., Jones, K., Kalish, J. M., Monteil, D. C., Pritchard, A. B., et al. (2025) · PEDIATRICS · doi:10.1542/peds.2025-072219 · Cited by 64
Hickingbotham, M. R., Wong, C., & Bowling, A. B. (2021) · Translational Behavioral Medicine · doi:10.1093/tbm/ibab085 · Cited by 59
Iovino, E. A., Caemmerer, J. M., & Chafouleas, S. M. (2021) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2021.103983 · Cited by 58
A Roadmap for US Robotics – From Internet to Robotics 2020 Edition
Christensen, H. I., Amato, N. M., Yanco, H. A., Matarić, M. J., Choset, H., Drobnis, A. W., Goldberg, K. Y., Grizzle, J. W., Hager, G. D., Hollerbach, J. M., et al. (2021) · Foundations and Trends in Robotics · doi:10.1561/2300000066 · Cited by 61
Carter, M. T., Srour, M., Au, P. Y. B., Buhaş, D., Dyack, S., Eaton, A. J., Inbar‐Feigenberg, M., Howley, H. E. A., Kawamura, A. A., Lewis, M. E. S., et al. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2022-108962 · Cited by 58
Knowns and unknowns about the neurobiology of stuttering
Neef, N. E., & Chang, S. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002492 · Cited by 70
Gregory, R. (2021) · Educational Research and Reviews · doi:10.5897/err2021.4128 · Cited by 55
“Current estimates indicate that 35 million Americans have a learning disability (LD), and dyslexia is by far the most diagnosed among all LDs (Zablotsky et al., 2019).”
BackgroundCasseus, M., Kim, W. J., & Horton, D. B. (2023) · Autism Research · doi:10.1002/aur.2894 · Cited by 53
“Additionally, there is a high level of consistency between results of the NSCH and other nationally representative surveys in estimating developmental disabilities including ASD (Kogan et al., 2018; Zablotsky et al., 2019).”
ResultLiu, L., Jiao, J., Yang, X., Zhang, J., Yu, H., Li, C., Pan, L., Ma, B., Sun, H., Zhang, J., et al. (2023) · Ophthalmology · doi:10.1016/j.ophtha.2023.02.002 · Cited by 53
Payne-Sturges, D., Taiwo, T. K., Ellickson, K. M., Mullen, H., Tchangalova, N., Anderko, L., Chen, A., & Swanson, M. (2023) · Environmental Health Perspectives · doi:10.1289/ehp11750 · Cited by 56
Ahn, Y., Sabouny, R., Villa, B. R., Yee, N. C., Mychasiuk, R., Uddin, G. M., Rho, J. M., & Shutt, T. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093266 · Cited by 55
“5% prevalence of autism spectrum disorder (ASD) in the United States [5].”
BackgroundInfluentialPrimary Care Framework to Monitor Preterm Infants for Neurodevelopmental Outcomes in Early Childhood
Davis, B. E., Leppert, M. L. O., German, K. R., Lehmann, C. U., Adams-Chapman, I. S., Noritz, G. H., Agrawal, R., Foster, J. E. A., Fremion, E., Frierson, S. L., et al. (2023) · PEDIATRICS · doi:10.1542/peds.2023-062511 · Cited by 59
Goodman, C. V., Green, R. R., DaCosta, A., Flora, D. B., Lanphear, B. P., & Till, C. (2023) · Environmental Health · doi:10.1186/s12940-023-01029-z · Cited by 56
“Included in the analysis were studies that [1] evaluated general, verbal, and/or nonverbal IQ and [2] reported the interaction by sex (i.e., interaction coefficient/ p -value) or effects separately by sex.”
BackgroundAssociations of Metals and Neurodevelopment: a Review of Recent Evidence on Susceptibility Factors
Bauer, J. A., Fruh, V., Howe, C. G., White, R. F., & Henn, B. C. (2020) · Current Epidemiology Reports · doi:10.1007/s40471-020-00249-y · Cited by 55
“Finally, a cross-sectional study of 6– 9-year-old Spanish children reported an inverse association between total urinary As and measures of attention [71]. Possible sex differences were examined, but none was observed. Other Behavioral Outcomes While limited, there is also some evidence that As may adversely impact no…”
InfluentialVariability in Cerebral Palsy Diagnosis
Aravamuthan, B. R., Fehlings, D. L., Shetty, S., Fahey, M. C., Gilbert, L. A., Tilton, A. H., & Kruer, M. C. (2021) · PEDIATRICS · doi:10.1542/peds.2020-010066 · Cited by 50
Worldwide national intervention of developmental screening programs in infant and early childhood
Kim, S. (2021) · Korean Journal of Pediatrics · doi:10.3345/cep.2021.00248 · Cited by 48
Environmental Toxicants and the Developing Brain
Wylie, A. C., & Short, S. J. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.01.007 · Cited by 48
“autism (32), are related to increasing environmental toxicant exposures (33).”
BackgroundTsamantioti, E., Lisonkova, S., Muraca, G. M., Örtqvist, A. K., & Razaz, N. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.03.028 · Cited by 50
Yu, J. A., Bayer, N. D., Beach, S. R., Kuo, D. Z., & Houtrow, A. J. (2022) · Academic Pediatrics · doi:10.1016/j.acap.2022.08.004 · Cited by 46
Using technology in special education: current practices and trends
Adewoyin, O., Akçayır, G., Ishola, O. M., & Epp, C. D. (2020) · Educational Technology Research and Development · doi:10.1007/s11423-020-09795-0 · Cited by 46
“The prevalence of cognitive and developmental disabilities has steadily increased over time (Boat and Wu 2015; Marquis et al. 2018; Zablotsky et al. 2019).”
BackgroundLinks Between Child and Adolescent Psychiatric Disorders and Cardiovascular Risk
Goldstein, B. I., & Korczak, D. J. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.06.023 · Cited by 47
Exercise Intervention in Treatment of Neuropsychological Diseases: A Review
Chen, Z., Lan, W., Yang, G., Li, Y., Xiang, J., Chen, L., Zhou, Y. N., & Li, S. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.569206 · Cited by 53
Inclusive practice for students with neurodevelopmental disorders in Sweden
Bölte, S., Leifler, E., Berggren, S., & Borg, A. (2021) · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology · doi:10.21307/sjcapp-2021-002 · Cited by 45
Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care
Russo, R. S., Gambello, M. J., Murphy, M. M., Aberizk, K., Black, E., Burrell, T. L., Carlock, G., Cubells, J. F., Epstein, M. T., España, R., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-020-01053-1 · Cited by 43
Three decades of ASD genetics: building a foundation for neurobiological understanding and treatment
Eyring, K. W., & Geschwind, D. H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab176 · Cited by 46
“A national survey of US children, conducted between 2009 and 2017, estimated the prevalence of neurodevelopmental disorders (NDDs) at about 1 in 6, or 16% (1).”
BackgroundIqbal, M. A., Broeckel, U., Levy, B., Skinner, S. A., Sahajpal, N., Rodriguez, V., Stence, A. A., Awayda, K. M., Scharer, G. H., Skinner, C. D., et al. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2022.12.005 · Cited by 46
Chua, J. Y. X., & Shorey, S. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-04893-1 · Cited by 44
Jarema, K. A., Hunter, D. L., Hill, B. N., Olin, J. K., Britton, K. N., Waalkes, M., & Padilla, S. (2022) · Toxics · doi:10.3390/toxics10050256 · Cited by 47
“The incidence of neurodevelopmental deficits in children is steadily increasing (reviewed in [1,2]), accompanied by warnings from many scientific fronts regarding the possible adverse effects of environmental chemicals on nervous system development [3–5].”
BackgroundDisruption of MeCP2–TCF20 complex underlies distinct neurodevelopmental disorders
Zhou, J., Hamdan, H., Yalamanchili, H. K., Pang, K., Pohodich, A. E., Lopez, J., Shao, Y., Osés-Prieto, J. A., Li, L., Kim, W., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119078119 · Cited by 44
Important Considerations for COVID-19 Vaccination of Children With Developmental Disabilities
Tinker, S. C., Cogswell, M. E., Peacock, G., & Ryerson, A. B. (2021) · PEDIATRICS · doi:10.1542/peds.2021-053190 · Cited by 42
“In 2015–2017, 1 in 6 children aged 3 to 17 years had a developmental disability (DD) such as cerebral palsy, autism spectrum disorder (ASD), or intellectual disability (ID).(1) DDs are a diverse group of chronic conditions that begin in childhood and can impact functioning throughout life.”
BackgroundMatias, S. L., Pearl, M., Lyall, K., Croen, L., Kral, T. V. E., Fallin, M. D., Lee, L., Bradley, C., Schieve, L. A., & Windham, G. C. (2021) · Obesity · doi:10.1002/oby.23228 · Cited by 42
“Children with (1) a previous ASD diagnosis, (2) an SCQ score ≥11, and/or (3) ASD symptoms noted by a SEED research clinician during the general developmental assessment were administered a full ASD developmental evaluation.”
BackgroundInfluentialSelf-citationMárquez-Caraveo, M. E., Rodríguez‐Valentín, R., Pérez-Barrón, V., Vázquez‐Salas, R. A., Sánchez‐Ferrer, J. C., de Castro, F., Allen‐Leigh, B., & Lazcano-Ponce, E. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-97551-6 · Cited by 52
Minor sex trafficking of girls with disabilities
Franchino-Olsen, H., Silverstein, H. A., Kahn, N. F., & Martin, S. L. (2020) · International Journal of Human Rights in Healthcare · doi:10.1108/ijhrh-07-2019-0055 · Cited by 41
Payne-Sturges, D., Cory‐Slechta, D. A., Puett, R. C., Thomas, S. B., Hammond, R. A., & Hovmand, P. S. (2021) · Environmental Health Perspectives · doi:10.1289/ehp7333 · Cited by 43
“…and Disability Trends over Time Developmental disabilities affect 1 in 6 children in the United States, and the rate has increased over time (Zablotsky et al. 2019); these conditions include learning disabilities, sensory deficits, developmental delays, cerebral palsy, autism, and attention…”
BackgroundInfluentialKildal, E. S.-M., Stadskleiv, K., Boysen, E. S., Øderud, T., Dahl, I.-L., Seeberg, T. M., Guldal, S., Strisland, F., Morland, C., & Hassel, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-86023-6 · Cited by 40
Makary, M. A., & Prasad, V. (2025) · JAMA · doi:10.1001/jama.2025.10116 · Cited by 43
Nguyen, U. T.-H., Tinsley, B., Sen, Y., Stein, J., Palacios, Y., Ceballos, A., Welch, C. J., Nzenkue, K., Penn, A., Murphy, L., et al. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.12.007 · Cited by 40
“These studies can be followed by analysis of NDDassociated neuronal phenotypes through examination of the simple neural structures of fruit flies.”
BackgroundInfluentialJeanne, M., Demory, H., Moutal, A., Vuillaume, M., Blesson, S., Thépault, R., Marouillat, S., Halewa, J., Maas, S. M., Motazacker, M. M., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.04.004 · Cited by 35
“Intellectual disabilities (IDs) define a group of frequently associated neurodevelopmental disorders (NDDs), which affect at least 1% of the general population and consequently represent a major public health issue.(1) NDDs are”
BackgroundThe effects of the exposure to neurotoxic elements on Italian schoolchildren behavior
Renzetti, S., Cagna, G., Calza, S., Conversano, M., Fedrighi, C., Forte, G., Giorgino, A., Guazzetti, S., Majorani, C., Oppini, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88969-z · Cited by 39
Nielsen, T. C., Nassar, N., Boulton, K., Guastella, A. J., & Lain, S. J. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05887-3 · Cited by 40
“…et al., 2021), the second reported a prevalence of 1.9% of 8 year old children based on abstraction of medical, education, and service records (Maenner et al., 2020), and the third reported a prevalence of 2.5% of children aged 3 to 17 based on a survey of parents (Zablotsky et al., 2019).”
BackgroundResultInfluentialModern Assessments of Intelligence Must Be Fair and Equitable
Holden, L. R., & Tanenbaum, G. J. (2023) · Journal of Intelligence · doi:10.3390/jintelligence11060126 · Cited by 46
Social cognition in autism and ADHD
Bölte, S. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106022 · Cited by 50
“A population-based survey from the USA estimated the prevalence of neurodevelopmental conditions at 17.8 % (Zablotsky et al., 2019).”
InfluentialThe cost-effectiveness of whole genome sequencing in neurodevelopmental disorders
Runheim, H., Pettersson, M., Hammarsjö, A., Nordgren, A., Henriksson, M., Lindstrand, A., Levin, L., & Soller, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-33787-8 · Cited by 41
Caruso, A., Gila, L., Fulceri, F., Salvitti, T., Micai, M., Baccinelli, W., Bulgheroni, M., & Scattoni, M. L. (2020) · Brain Sciences · doi:10.3390/brainsci10060379 · Cited by 39
Computational Decision Support System for ADHD Identification
Silva, S. D., Dayarathna, S., Ariyarathne, G., Meedeniya, D., Jayarathna, S., & Michalek, A. M. P. (2020) · Machine Intelligence Research · doi:10.1007/s11633-020-1252-1 · Cited by 38
Pierson, L. M., Thompson, J., Ganz, J. B., Wattanawongwan, S., Haas, A., & Yllades, V. A. (2020) · American Journal of Speech-Language Pathology · doi:10.1044/2020_ajslp-20-00037 · Cited by 39
A transdiagnostic approach to neurodiversity in a representative population sample: The N+ 4 model
Apperly, I. A., Lee, R., van der Kleij, S. W., & Devine, R. T. (2024) · JCPP Advances · doi:10.1002/jcv2.12219 · Cited by 37
“Our selection of 7 broader phenotype measures corresponded to some of the most frequent neuro-developmental conditions (e.g. as identified by Cleaton & Kirby, 2018, Zablotsky et al., 2019, Francés et al., 2022, Straub et al., 2022), and 6/ 7 had two or more subscales.”
BackgroundCanals, J., Morales‐Hidalgo, P., Voltas, N., & Hernández‐Martínez, C. (2024) · Autism Research · doi:10.1002/aur.3146 · Cited by 37
“…comprise a group of persistent conditions with an early onset in childhood, commonly addressed within mental health services (Hansen et al., 2018; Zablotsky et al., 2019). attention deficit hyperactivity disorder (ADHD) and autism are among these conditions, which have demonstrated a significant…”
BackgroundFinnigan, K. A. (2024) · Land · doi:10.3390/land13050636 · Cited by 37
Gesù, C. M. D., Matz, L. M., & Buffington, S. A. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.05.003 · Cited by 47
Massuti, R., Maia, C. R. M., Campani, F., Sônego, M. L., Amaro, J., Akutagava‐Martins, G. C., Tessari, L., Polanczyk, G. V., Cortese, S., & Rohde, L. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.001 · Cited by 42
Metadata
- Authors
- Zablotsky, B., Black, L. I., Maenner, M. J., Schieve, L. A., Danielson, M. L., Bitsko, R. H., Blumberg, S. J., Kogan, M. D., & Boyle, C. A.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Health Resources and Services Administration (US)
- Corresponding author
- Zablotsky, Benjamin
- ORCID
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2019-10-01
- Volume
- 144
- Issue
- 4
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC7076808
- OpenAlex
- W2976851556
- Cited by
- 1,217
- References
- 54
- Citations by year
- 2026: 116 · 2025: 189 · 2024: 210 · 2023: 218 · 2022: 218 · 2021: 184 · 2020: 75 · 2019: 4
- FWCI
- 111.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health and Medical Studies
- Keywords
- developmental disabilities, prevalence trends, attention deficit hyperactivity disorder, autism spectrum disorder, intellectual disability, developmental delay, learning disabilities, cerebral palsy, hearing loss, blindness, seizures, stuttering, socioeconomic disparities, demographic disparities, children, United States
- MeSH terms
- Autism Spectrum Disorder, Adolescent, Age Factors, Attention Deficit Disorder with Hyperactivity, Blindness, Cerebral Palsy, Child, Developmental Disabilities, Child, Preschool, Educational Status, Female, Humans, Male, Intellectual Disability, Population Dynamics, Seizures, Sex Factors, Socioeconomic Factors, Stuttering, United States, Prevalence, Insurance Coverage, Hearing Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
